SVA [SINOVAC BIOTECH] 6-K: Sinovac Reports Positive Preliminary Phase I Clinical Trial
[Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group Unblinded Results Show Good Safety Profile and Preliminary Immunogenicity Source: Sinovac Biotech Ltd. On Thursday March 10, 2011, 8:00 am EST BEIJING, March 10, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq:SVA - News), a leading provider of biopharmaceutical products in China, announced today the unblinding] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.]